Treatment of age-related macular degeneration: focus on ranibizumab
Martin S Spitzer, Focke Ziemssen, Karl U Bartz-Schmidt, Faik Gelisken, Peter SzurmanTuebingen University Eye Center, University of Tuebingen, GermanyAbstract: Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A, significantly slows down loss of vision and causes...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-03-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/treatment-of-age-related-macular-degeneration-focus-on-ranibizumab-a360 |